18 November 2022
International Chemical Investors (ICIG) has successfully closed the acquisition of inprotec AG from Paragon Partners.
inprotec offers its clients longstanding experience as the leading contract manufacturer for industrial drying and granulation services using fluidized-bed spray granulation, coating, matrix encapsulation and spray drying technologies.
With approximately €65 million of sales and 270 employees, the company is characterized by a superb reputation, strong customer relationships and operates two production sites in Heitersheim and Genthin.
The signing of the transaction was announced in late October and has since received the customary antitrust clearance approvals.
inprotec AG, based in Heitersheim, offers its clients longstanding experience as the leading contract manufacturer for industrial drying and granulation services using fluidized-bed spray granulation, coating, matrix encapsulation and spray drying technologies. As an expert in this field, inprotec is the partner of choice to realize innovative and complex production processes and to overcome customers’ capacity and know-how bottlenecks. In recent years the company has handled over 2,500 starting materials and intermediate products across several industries (consumer goods, animal feed, cosmetics industry, plastic additives). inprotec AG operates two production sites in Heitersheim and Genthin today and employs c. 270 employees. For further information please refer to www.inprotec-ag.de.
International Chemical Investors is a privately owned industrial group with total sales of around €4 billion. ICIG is focusing on four main platforms: Fine Chemicals under the WeylChem brand, Chlorovinyls under the Vynova brand, Compounds under the Benvic brand and Enterprises which comprises specialized companies active in industrial drying and granulation services, fermentation products, viscose filament, activated carbon and wood protection chemicals (including “inprotec”, “Corden BioChem”, “ENKA”, “CarboTech”, and “Rütgers Organics”). Since inception in 2004, ICIG has grown to operate more than 20 independent chemicals and pharmaceutical businesses, all of which have origins in major global chemical or pharmaceutical corporations. Today, ICIG companies employ approximately 4,800 employees and operate more than 30 manufacturing facilities in Europe and the United States. For further information please refer to www.ic-investors.com.